About Iantrek

Iantrek develops microinterventional surgical technologies, including the CycloPen™ and AlloFlo™, designed for precise cyclodialysis and enhanced uveoscleral outflow in glaucoma treatment. These systems address the challenges of traditional glaucoma surgeries by providing controlled, minimally invasive options that improve patient outcomes and reduce recovery times.

```xml <problem> Traditional glaucoma surgeries often lack precision and can result in extended recovery times and unpredictable outcomes. Existing methods for cyclodialysis and enhancing uveoscleral outflow may not provide the necessary control for effective and consistent results. </problem> <solution> Iantrek develops microinterventional surgical technologies designed to enhance precision and control in glaucoma treatment. The CycloPen™ system facilitates controlled creation or modification of a cyclodialysis, while AlloFlo™ is designed to enhance uveoscleral outflow through precision scleral reinforcement. These technologies offer minimally invasive options aimed at improving patient outcomes and reducing recovery times compared to traditional surgical approaches. The C-Rex™ system transforms goniotomy with a fully circumferential, excisional, and titratable design. </solution> <features> - CycloPen™: Ergonomically designed for controlled creation or modification of a cyclodialysis. - AlloFlo™: Bio-Interventional solution designed to naturally enhance uveo-scleral outflow through precision scleral reinforcement. - C-Rex™: Fully circumferential, excisional, and titratable goniotomy system. - Micro-interventional nitinol instrumentation for precise anterior segment surgery. </features> <target_audience> The primary target audience includes ophthalmic surgeons specializing in glaucoma treatment and seeking more precise and minimally invasive surgical options. </target_audience> ```

What does Iantrek do?

Where is Iantrek located?

Iantrek is based in White Plains, United States.

When was Iantrek founded?

Iantrek was founded in 2019.

Location

White Plains, United States

Founded

2019

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Iantrek

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

iantrekmed.com

Founded 2019 – White Plains, United States

Funding

No funding information available.

Team

No team information available.

Company Description

Problem

Traditional glaucoma surgeries often lack precision and can result in extended recovery times and unpredictable outcomes. Existing methods for cyclodialysis and enhancing uveoscleral outflow may not provide the necessary control for effective and consistent results.

Solution

Iantrek develops microinterventional surgical technologies designed to enhance precision and control in glaucoma treatment. The CycloPen™ system facilitates controlled creation or modification of a cyclodialysis, while AlloFlo™ is designed to enhance uveoscleral outflow through precision scleral reinforcement. These technologies offer minimally invasive options aimed at improving patient outcomes and reducing recovery times compared to traditional surgical approaches. The C-Rex™ system transforms goniotomy with a fully circumferential, excisional, and titratable design.

Features

CycloPen™: Ergonomically designed for controlled creation or modification of a cyclodialysis.

AlloFlo™: Bio-Interventional solution designed to naturally enhance uveo-scleral outflow through precision scleral reinforcement.

C-Rex™: Fully circumferential, excisional, and titratable goniotomy system.

Micro-interventional nitinol instrumentation for precise anterior segment surgery.

Target Audience

The primary target audience includes ophthalmic surgeons specializing in glaucoma treatment and seeking more precise and minimally invasive surgical options.